Skip to main content
Year archive

HANALL BIOPHARMA CO.,LTD — 2026 filings

All 27 regulatory filings released by HANALL BIOPHARMA CO.,LTD (009420) in 2026, sourced directly from the official regulator.

27 Filings
2026 Period
2026 filings (27)
Filing Released Lang
[기재정정]투자판단관련주요경영사항
Regulatory Filings
2026-05-20 Korean
분기보고서 (2026.03)
Interim / Quarterly Report Q1 2026
2026-05-15 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Regulatory Filings
2026-05-06 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Regulatory Filings
2026-05-06 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Regulatory Filings
2026-05-06 Korean
자기주식처분결과보고서
Regulatory Filings
2026-05-06 Korean
최대주주등소유주식변동신고서
Regulatory Filings
2026-05-06 Korean
주요사항보고서(자기주식처분결정)
Transaction in Own Shares
2026-04-29 Korean
연결재무제표기준영업(잠정)실적(공정공시)
Earnings Release Q1 2026
2026-04-29 Korean
기업설명회(IR)개최(안내공시)
Investor Presentation
2026-04-13 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Major Shareholding Notification
2026-04-07 Korean
투자판단관련주요경영사항
Regulatory Filings
2026-04-02 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification
2026-04-01 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information
2026-03-27 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2026-03-26 Korean
대표이사(대표집행임원)변경(안내공시)
Board/Management Information
2026-03-26 Korean
사업보고서 (2025.12)
Audit Report / Information FY 2025
2026-03-18 Korean
자기주식처분결과보고서
Transaction in Own Shares
2026-03-11 Korean
주요사항보고서(자기주식처분결정)
Transaction in Own Shares
2026-03-09 Korean
감사보고서제출
Audit Report / Information FY 2025
2026-03-09 Korean
자기주식처분결과보고서
Transaction in Own Shares
2026-03-03 Korean
주주총회소집결의
Proxy Solicitation & Information Statement
2026-02-25 Korean
주요사항보고서(자기주식처분결정)
Transaction in Own Shares
2026-02-25 Korean
주주총회소집공고
Proxy Solicitation & Information Statement
2026-02-25 Korean
매출액또는손익구조30%(대규모법인은15%)이상변경
Earnings Release FY 2025
2026-01-21 Korean
연결재무제표기준영업(잠정)실적(공정공시)
Earnings Release Q4 2025
2026-01-21 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification
2026-01-02 Korean